{"entity":{"id":"bmc-cancer","kind":"journal","name":"BMC cancer","aka":["BMC Cancer"],"tldr":"BMC Cancer is a large open access journal that takes sound research on any aspect of cancer, including study protocols, and is read by clinicians and researchers worldwide.","summary":"BMC Cancer was launched in 2001 by BioMed Central in London and is published by BMC, part of Springer Nature. Its aims and scope describe an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers, and welcomes work in molecular and cellular biology, genetics, epidemiology and clinical trials; it also publishes study protocols. The journal uses single anonymised peer review and publishes review reports with articles. It is listed in DOAJ with CC BY and CC BY-NC-ND licences and an article processing charge. Indexed in MEDLINE.","asOf":"2026-09-10","links":[{"label":"Homepage","url":"https://bmccancer.biomedcentral.com/"},{"label":"NLM Catalog","url":"https://www.ncbi.nlm.nih.gov/nlmcatalog/100967800"},{"label":"DOAJ record","url":"https://doaj.org/toc/1471-2407"}],"tags":[],"related":["pubmed-europepmc"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["clinical-trial"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"publisher":"BMC (Springer Nature)","url":"https://bmccancer.biomedcentral.com/","issn":"1471-2407","scope":"clinical oncology and cancer research","access":"open-access","founded":2001,"matchNames":["BMC Cancer","BMC cancer"]},"route":"/journals/bmc-cancer/","neighbours":{"collection":[{"id":"pubmed-europepmc","kind":"collection","name":"PubMed & Europe PMC","route":"/collections/pubmed-europepmc/"}],"term":[{"id":"clinical-trial","kind":"term","name":"Clinical trial","route":"/terms/clinical-trial/"}],"paper":[{"id":"paper-sun-bmc-cancer","kind":"paper","name":"Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials","route":"/key-papers/paper-sun-bmc-cancer/"},{"id":"paper-barchuk-registry-completeness-bmc-cancer-2023","kind":"paper","name":"Completeness of regional cancer registry data in north-west Russia, 2008 to 2017","route":"/key-papers/paper-barchuk-registry-completeness-bmc-cancer-2023/"},{"id":"paper-xm22-03-bondarenko-bmc-cancer-2013","kind":"paper","name":"Efficacy and safety of lipegfilgrastim versus pegfilgrastim in breast cancer patients receiving doxorubicin and docetaxel (XM22-03)","route":"/key-papers/paper-xm22-03-bondarenko-bmc-cancer-2013/"},{"id":"paper-erivance-bmc-cancer-2017-update","kind":"paper","name":"Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study","route":"/key-papers/paper-erivance-bmc-cancer-2017-update/"},{"id":"paper-gain-trial-protocol-bmc-cancer-2020","kind":"paper","name":"Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) - a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)- the AIO/ CALGP/ ACO- GAIN-trial","route":"/key-papers/paper-gain-trial-protocol-bmc-cancer-2020/"}],"person":[{"id":"johanna-mattson","kind":"person","name":"Johanna Mattson","route":"/people/johanna-mattson/"}]}}